BÖMER ULF,HÜBSCH WALTER,BROHM DIRK,HEROULT MELANIE,COLLIN MARIE-PIERRE,LUSTIG KLEMENS,GRÜNEWALD SYLVIA,VÖHRINGER VERENA,LOBELL MARIO
申请号:
NZ62507312
公开号:
NZ625073A
申请日:
2012.12.10
申请国别(地区):
NZ
年份:
2016
代理人:
摘要:
Provided are disubstituted 5-(1-benzothiophen-2-yl) pyrrolo[2,1-f][1,2,4]triazin-4-amine compounds of the general formula (I), wherein the variables are as defined in the specification. Examples of the compounds include 4-{ [4-Amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl} piperazin-2-one and 4-{ [ 4-Amino-7-(ethoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]methyl} piperazin-2-one. The compounds are FGFR kinase inhibitors. The compounds may be useful in the treatment of cancer.